[TVTX] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[TVTX] Travere Therapeutics, Inc.
Announcement Date
05-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- -47.31%
YoY- -41.03%
Quarter Report
TVTX's Result
TVTX's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 55,868 53,496 54,167 48,487 57,249 68,217 54,617 1.51%
PBT -65,760 -69,511 -66,979 -75,919 -51,569 -35,596 -38,963 41.62%
Tax 63 145 53 52 4 43 49 18.18%
NP -65,823 -69,656 -67,032 -75,971 -51,573 -35,639 -39,012 41.59%
Tax Rate - - - - - - - -
Total Cost 121,691 123,152 121,199 124,458 108,822 103,856 93,629 19.03%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -117.82 -130.21 -123.75 -156.68 -90.09 -52.24 -71.43 39.47%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -1.03 -1.09 -1.05 -1.20 -0.84 -0.59 -0.64 37.21%
EPS Diluted -1.03 -1.09 -1.05 -1.20 -0.84 -0.59 -0.64 37.21%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.